HER2 Support Group Forums - View Single Post - HER2-TPMC proves to be a reasonable alternative for HER2-positive cancer chemotherape

News · 05-15-2023, 06:42 PM

Announcing a new article publication for BIO Integration journal. Antibody-drug conjugates (ADCs) have the following advantages: target specificity; wide therapeutic index; and prolonged circulation half-life.

More...

05-15-2023, 06:42 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,984	HER2-TPMC proves to be a reasonable alternative for HER2-positive cancer chemotherape Announcing a new article publication for BIO Integration journal. Antibody-drug conjugates (ADCs) have the following advantages: target specificity; wide therapeutic index; and prolonged circulation half-life. More...